The Thirty-Year Influence of a Regional Consortium on Quality Improvement in Cardiac Surgery.
The Northern New England Cardiovascular Disease Study Group (NNECDSG) was founded in 1987 as a regional consortium to improve cardiovascular quality in Maine, New Hampshire and Vermont. We sought to assess the longitudinal impact of the NNECDSG on quality and cost of coronary artery bypass grafting (CABG) over the past 30-years. Patients undergoing isolated CABG at five medical centers from 1987 - 2017 were retrospectively reviewed (n=67,942). They were divided into four time periods, 1987-1999 (n=36,885), 2000-2005 (n=14,606), 2006-2011(n=8,470), and 2012-2017 (n=7,981). The first period was the time the NNECDSG initiated a series of quality improvement initiatives including data feedback, quality improvement training, process mapping, and site visits. Throughout four time intervals, there was a consistent decline in in-hospital mortality from 3.4% to 1.8% despite an increase in predicted risk of mortality (p<0.001). There was a significant decline in in-hospital morbidity including return to the operating room for bleeding, acute kidney injury, mediastinitis, and low output failure (p<0.001). Median length of stay decreased from 7 to 5 days (p<0.001), which translated into potential savings of $82,722,023. There was a decrease in use of red blood cells from 3.1 units per patient to 2.6 units in the most current time, which translated into potential savings of $1,985,456. Utilizing collaborative quality improvement initiatives, the NNECDSG has succeeded in significant, sustained improvements in quality and cost for CABG over the past 30-years. These data support the utility of a regional consortium in improving quality.